Kim was appointed as Professor of Applied Dermatology Research at the University of Nottingham in August 2013, and is currently Co-Director of the Centre of Evidence Based Dermatology and Deputy Head of Division for the Divsion of Rheumatology, Orthopaedics and Dermatology..
She joined the unit in 1999 as a Research Associate, and was responsible for the design and conduct of a randomised controlled trial of topical corticosteroids for the treatment of eczema in children. Since then, Kim has worked in various roles within the unit, with a focus on independent randomised controlled trials (including conditions such as eczema, cellulitis, vitiligo, verrucae, and rare skin diseases).
Her particular interests are in the design and conduct of dermatology clinical trials, and in clinical trial methodology (especially outcomes research). She is a founder member of the UK Dermatology Clinical Trials Network, and is a member of the Executive Committee for the international Harmonizing Outcome Measures for Eczema (HOME) initiative.
Kim is a panel member for the National Institute for Health Research Programme Grants for Applied Research programme (NIHR PGfAR), is an adviser to the National Institute for Clinical Excellence (NICE), and an affiliate member of the National Institute for Health Research Health Technology Assessment (NIHR HTA) Commissioning Board.
- Clinical trial design and conduct
- Outcome measures
- Consensus methodologies
- Patient and public involvement
The Centre of Evidence Based Dermatology runs a popular 3-day annual course - Getting to grips with evidence-based dermatology.
NIHR Programme Grant for Applied Research: Eczema Care Online
NIHR Health Technology Assessment: HI-light Vitiligo Trial
HOME initiative: Harmonizing Outcome Measures for Eczema
THOMAS, K.S., CROOK, A.M., NUNN, A.J., FOSTER, K.A., MASON, J.M., CHALMERS, J.R., NASR, I.S., BRINDLE, R.J., ENGLISH, J., MEREDITH, S.K., REYNOLDS, N.J., DE BERKER D., MORTIMER, P.S. and WILLIAMS, H.C., 2013. Penicillin to prevent recurrent leg cellulitis New England Journal of Medicine. 368(18), 1695-1703
ORMEROD AD, THOMAS KS, CRAIG FE, MITCHELL E, GREENLAW N, NORRIE J, MASON JM, WALTON S, JOHNSTON GA, WILLIAMS HC and UK DERMATOLOGY CLINICAL TRIALS NETWORK’S STOP GAP TEAM, 2015. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ (Clinical research ed.). 350, h2958
THOMAS, K. S., BATCHELOR, J. M., BATH-HEXTALL, F., CHALMERS, J. R., CLARKE, T., CROWE, S., DELAMERE, F. M., ELEFTHERIADOU, V., EVANS, N., FIRKINS, L., GREENLAW, N., LANSBURY, L., LAWTON, S., LAYFIELD, C., LEONARDI-BEE, J., MASON, J., MITCHELL, E., NANKERVIS, H., NORRIE, J., NUNN, A., ORMEROD, A. D., PATEL, R., PERKINS, W., RAVENSCROFT, J. C., SCHMITT, J., SIMPSON, E., WHITTON, M. E. and WILLIAMS, H. C., 2016. A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease Programme Grants Appl Res. 4(18),
THOMAS KS, BRADSHAW LE, SACH TH, COWDELL F, BATCHELOR JM, LAWTON S, HARRISON EF, HAINES RH, AHMED A, DEAN T, BURROWS NP, POLLOCK I, BUCKLEY HK, WILLIAMS HC, LLEWELLYN J, CRANG C, GRUNDY JD, GUINESS J, GRIBBIN A, WAKE EV, MITCHELL EJ, BROWN SJ and MONTGOMERY AA, 2017. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial. Health technology assessment (Winchester, England). 21(16), 1-260